TRI-MOXI Trademark

Trademark Overview

On Monday, August 3, 2015, a trademark application was filed for TRI-MOXI with the United States Patent and Trademark Office. The USPTO has given the TRI-MOXI trademark a serial number of 86712769. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, March 17, 2023. This trademark is owned by IMPRIMIS PHARMACEUTICALS, INC.. The TRI-MOXI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical compositions for ocular or intraocular surgery
tri-moxi

General Information

Serial Number86712769
Word MarkTRI-MOXI
Filing DateMonday, August 3, 2015
Status710 - CANCELLED - SECTION 8
Status DateFriday, March 17, 2023
Registration Number5034588
Registration DateTuesday, September 6, 2016
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 21, 2016

Trademark Statements

Goods and ServicesPharmaceutical compositions for ocular or intraocular surgery

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, March 17, 2023
Primary Code005
First Use Anywhere DateThursday, January 1, 2015
First Use In Commerce DateFriday, January 16, 2015

Trademark Owner History

Party NameHARROW IP, LLC
Party Type32 - New Owner After Registration
Legal Entity Type16 - Limited Liability Company
AddressTEMECULA, CA 92590
Party NameHARROW HEALTH, INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressSAN DIEGO, CA 92130
Party NameIMPRIMIS PHARMACEUTICALS, INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92130
Party NameIMPRIMIS PHARMACEUTICALS, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92130
Party NameIMPRIMIS PHARMACEUTICALS, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92130

Trademark Events

Event DateEvent Description
Wednesday, April 12, 2023ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Friday, March 17, 2023CANCELLED SEC. 8 (6-YR)
Monday, September 6, 2021COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, October 27, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, October 27, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, October 27, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, September 14, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, September 14, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, September 14, 2020TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Monday, September 14, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, September 14, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, September 14, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, November 27, 2019ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, November 6, 2019AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, January 16, 2019AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, August 2, 2017ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, February 22, 2017TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, September 6, 2016REGISTERED-PRINCIPAL REGISTER
Tuesday, June 21, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 21, 2016PUBLISHED FOR OPPOSITION
Wednesday, June 1, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, May 13, 2016LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, May 9, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, April 16, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, April 15, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, April 15, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, December 3, 2015NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
Wednesday, December 2, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, December 2, 2015NON-FINAL ACTION E-MAILED
Wednesday, December 2, 2015NON-FINAL ACTION WRITTEN
Wednesday, December 2, 2015USE AMENDMENT ACCEPTED
Thursday, November 5, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, November 5, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, November 4, 2015ASSIGNED TO LIE
Wednesday, October 14, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, October 15, 2015AMENDMENT TO USE PROCESSING COMPLETE
Thursday, October 15, 2015USE AMENDMENT FILED
Wednesday, October 14, 2015TEAS AMENDMENT OF USE RECEIVED
Wednesday, September 30, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, September 30, 2015NON-FINAL ACTION E-MAILED
Wednesday, September 30, 2015NON-FINAL ACTION WRITTEN
Tuesday, September 29, 2015ASSIGNED TO EXAMINER
Friday, August 7, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, August 6, 2015NEW APPLICATION ENTERED

Related Keywords

moxi surgery intraocular ocular compositions pharmaceutical